임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

28건 표시

1상모집 중· Healthy
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
리드: JW중외제약
상세 →NCT07514780
1상완료· Healthy
To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
리드: JW중외제약
상세 →NCT07374406
1상완료· Healthy Male Adults
To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
리드: JW중외제약
상세 →NCT07036458
1상완료· Healthy Volunteers
PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers
리드: JW중외제약
상세 →NCT06665425
1상완료· Healthy
To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105
리드: JW중외제약
상세 →NCT06754943
1상모집 중· Healthy
To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers
리드: JW중외제약
상세 →NCT06703710
1상완료· Healthy
To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107
리드: JW중외제약
상세 →NCT06816719
1상완료· Healthy
PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers
리드: JW중외제약
상세 →NCT06435442
1상완료· Healthy
To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers
리드: JW중외제약
상세 →NCT06361277
1상완료· Healthy
To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers
리드: JW중외제약
상세 →NCT06378684
1상완료· Healthy
To Evaluate the Safety and PK Characteristics in Healthy Volunteers
리드: JW중외제약
상세 →NCT06355349
1상완료· Healthy
To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers
리드: JW중외제약
상세 →NCT05784155
1상완료· Healthy Volunteers
A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People
리드: JW중외제약
상세 →NCT05508776
1상완료· Healthy
To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers
리드: JW중외제약
상세 →NCT05433844
1상완료· Healthy
To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers
리드: JW중외제약
상세 →NCT05463497
1상완료· Healthy, Renal Impairment
A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment
리드: JW중외제약
상세 →NCT05198778
1상완료· Healthy
To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers
리드: JW중외제약
상세 →NCT05351840
1상완료· Healthy
A Trial to Evaluate the Effect of Food on LEO 152020
리드: JW중외제약
상세 →NCT04203836
1상완료· Healthy
Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers
리드: JW중외제약
상세 →NCT04018170
1상완료· Multiple Myeloma
Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients
리드: JW중외제약
상세 →NCT02426723
1상완료· Healthy
Phase 1 Study(Additional) of URC102 in Healthy Subjects
리드: JW중외제약
상세 →NCT02524678
1상완료· Healthy
Phase 1 Study of URC102 in Healthy Subjects
리드: JW중외제약
상세 →NCT01953497
1상완료· Hyperlipidemia
To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet
리드: JW중외제약
상세 →NCT01764178
1상완료· Hyperlipidemia
Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects
리드: JW중외제약
상세 →NCT01406431
1상완료· Acute Myeloid Leukemia
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
리드: JW중외제약
상세 →NCT01398462
1상완료· Healthy
Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.
리드: JW중외제약
상세 →NCT01443221
1상완료· Healthy
Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)
협력: JW중외제약
상세 →NCT01232049
1상완료· Type 2 Diabetes Mellitus
Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
협력: JW중외제약
상세 →NCT01422590

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.